Research Program: Cancer Discovery Platforms Bridging the Engineering-Biology Continuum
Strategic Theme: Natural & Model Systems
Kim Selting has made major contributions to both human and veterinary oncology through development, design, and reporting in animal clinical trials and the application of radiation therapy to companion animals. During clinical research, Selting has explored the use of biomarkers in veterinary cancer medicine, making discoveries in the early detection of cancer relapse and chemotherapy-induced toxicity to provide early intervention for patients. Selting has evaluated the use of new anti-cancer chemotherapy drugs, evaluating methods that can be translated to human medicine. She is certified in radiation oncology, contributing to the body of knowledge surrounding radiation therapy of cancer.
Selting completed her undergraduate and veterinary studies at Colorado State University. She has worked in New York City’s Animal Medical Center and spent several years in private practice. She previously held a faculty position at the University of Missouri, until she joined the University of Illinois College of Veterinary Medicine.